Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Core Laboratories Inc
(NY:
CLB
)
18.90
UNCHANGED
Official Closing Price
Updated: 7:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Core Laboratories Inc
< Previous
1
2
3
Next >
Core Laboratories (CLB) Q3 2024 Earnings Call Transcript
October 24, 2024
CLB earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Core Laboratories (CLB) Q2 2024 Earnings Call Transcript
July 25, 2024
CLB earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
CLB Stock Earnings: Core Laboratories Beats EPS, Misses Revenue for Q2 2024
July 24, 2024
CLB stock results show that Core Laboratories beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Sanofi Reports Strong Earnings, Joins Kirby, Sonic Automotive, Union Pacific And Other Big Stocks Moving Higher On Thursday
April 25, 2024
Via
Benzinga
CLB Stock Earnings: Core Laboratories Beats EPS, Beats Revenue for Q1 2024
April 24, 2024
CLB stock results show that Core Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
A Preview Of Core Laboratories's Earnings
January 30, 2024
Via
Benzinga
Core Laboratories (CLB) Q2 2023 Earnings Call Transcript
July 27, 2023
CLB earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Earnings Preview: Core Laboratories
July 25, 2023
Via
Benzinga
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
February 20, 2024
Cannabis multi-state operator Cresco Labs kicked off February by announcing the promotion of Greg Butler to the position of president. Tom Shuman, a CPG sales and marketing veteran, agreed to serve as...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Core Laboratories (CLB) Q4 2023 Earnings Call Transcript
February 01, 2024
CLB earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio
January 09, 2024
Discover the hidden pitfalls in the investment world with a deep dive into these three stocks to sell now to protect your portfolio.
Via
InvestorPlace
3 Oil Stocks to Sell in January Before They Crash and Burn
January 02, 2024
You have until the end of the month to dump these oil stocks before they crash. Do you have these three in your portfolio?
Via
InvestorPlace
4 Analysts Have This to Say About Core Laboratories
June 30, 2023
Via
Benzinga
The Latest Analyst Ratings for Core Laboratories
May 01, 2023
Via
Benzinga
Core Laboratories (CLB) Q1 2023 Earnings Call Transcript
April 28, 2023
CLB earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Earnings Scheduled For January 31, 2024
January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
Via
Benzinga
Core Laboratories (CLB) Q4 2022 Earnings Call Transcript
February 02, 2023
CLB earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Core Laboratories (CLB) Q3 2023 Earnings Call Transcript
November 02, 2023
CLB earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Northrop Grumman, General Dynamics, Lockheed Martin And Other Big Stocks Moving Higher On Monday
October 09, 2023
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Halliburton And Core Laboratories Collaborate To Accelerate Digital Rock Data Solutions
October 09, 2023
Halliburton Company (NYSE: HAL) and Core Laboratories Inc. (NYSE: CLB) announced a strategic alliance aimed at expediting the delivery of
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
June 30, 2023
Via
Benzinga
Core Laboratories's Earnings: A Preview
January 31, 2023
Via
Benzinga
Crude Oil Rises 2%; LumiraDx Shares Spike Higher
June 21, 2023
U.S. stocks traded lower toward the end of trading, with Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.04% to 34,040.13 while the NASDAQ fell 0.77% to 13,562.00. The S&P...
Via
Benzinga
Russia-Saudi Output Clashes, Goldman Forecast Cuts Shake The Market: 5 Oil Services Stocks That Are Weathering the Storm
June 12, 2023
Via
Benzinga
Nasdaq, Methanex And Other Big Stocks Moving Lower On Monday
June 12, 2023
U.S. stocks traded higher, with the Nasdaq Composite rising around 70 points on Monday. Here are some big stocks recording losses in today’s session. Beneficient (NASDAQ: BENF) shares fell 17% to...
Via
Benzinga
Why Core Laboratories, Gran Tierra Energy, and NexTier Oilfield Solutions Rallied Today
April 03, 2023
OPEC members surprised the market with another oil production cut, which lifted these small-cap oil-related stocks.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
April 18, 2023
Via
Benzinga
Why Devon Energy, Phillips 66, and Core Laboratories All Slumped Today
February 17, 2023
A big inventory build in the U.S. and fears of higher interest rates caused these oil-related stocks to fall.
Via
The Motley Fool
Earnings Scheduled For February 1, 2023
February 01, 2023
Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023
January 09, 2023
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.